Julie Vaillancourt

713 total citations
15 papers, 495 citations indexed

About

Julie Vaillancourt is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Julie Vaillancourt has authored 15 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Hematology. Recurrent topics in Julie Vaillancourt's work include Rheumatoid Arthritis Research and Therapies (4 papers), Autoimmune and Inflammatory Disorders Research (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Julie Vaillancourt is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (4 papers), Autoimmune and Inflammatory Disorders Research (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Julie Vaillancourt collaborates with scholars based in Canada, United States and United Kingdom. Julie Vaillancourt's co-authors include John S. Sampalis, Lisa Dolovich, Antonio Addis, TR Einarson, Gideon Koren, Emmanouil Rampakakis, Majed Khraishi, Don MacDonald, Afisi Ismaila and Zhen Su and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Surgery and CHEST Journal.

In The Last Decade

Julie Vaillancourt

15 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Vaillancourt Canada 8 150 110 93 85 77 15 495
Francisco J. Schneuer Australia 14 108 0.7× 214 1.9× 41 0.4× 60 0.7× 214 2.8× 40 688
Mitsuyo Kinjo Japan 10 43 0.3× 39 0.4× 39 0.4× 69 0.8× 108 1.4× 45 497
Erik van Beek Netherlands 17 178 1.2× 322 2.9× 65 0.7× 38 0.4× 51 0.7× 32 708
Tuncay Küçüközkan Türkiye 15 199 1.3× 154 1.4× 68 0.7× 22 0.3× 126 1.6× 60 632
Arie Dekel Israel 16 222 1.5× 173 1.6× 41 0.4× 47 0.6× 267 3.5× 53 776
Joseph Onwude United Kingdom 17 166 1.1× 280 2.5× 42 0.5× 106 1.2× 135 1.8× 50 710
Ümit Göktolga Türkiye 17 308 2.1× 177 1.6× 96 1.0× 38 0.4× 130 1.7× 71 837
Rivka Farkash Israel 14 181 1.2× 211 1.9× 79 0.8× 15 0.2× 120 1.6× 57 597
Howard T. Sharp United States 17 144 1.0× 91 0.8× 94 1.0× 82 1.0× 376 4.9× 37 971
Chiann‐Yi Hsu Taiwan 13 46 0.3× 21 0.2× 110 1.2× 31 0.4× 163 2.1× 91 580

Countries citing papers authored by Julie Vaillancourt

Since Specialization
Citations

This map shows the geographic impact of Julie Vaillancourt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Vaillancourt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Vaillancourt more than expected).

Fields of papers citing papers by Julie Vaillancourt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Vaillancourt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Vaillancourt. The network helps show where Julie Vaillancourt may publish in the future.

Co-authorship network of co-authors of Julie Vaillancourt

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Vaillancourt. A scholar is included among the top collaborators of Julie Vaillancourt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Vaillancourt. Julie Vaillancourt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Haraoui, Boulos, Majed Khraishi, D. Choquette, et al.. (2024). Tofacitinib Safety and Effectiveness in Canadian Patients with Rheumatoid Arthritis by Cardiovascular Risk Enrichment: Subanalysis of the CANTORAL Study. Rheumatology and Therapy. 11(6). 1629–1648. 1 indexed citations
2.
Haraoui, Boulos, Majed Khraishi, D. Choquette, et al.. (2022). Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study. Arthritis Care & Research. 75(2). 240–251. 3 indexed citations
3.
Stein, Michael Ashley, Julie Vaillancourt, Emmanouil Rampakakis, & John S. Sampalis. (2020). Prospective observational study to evaluate the use of musculoskeletal ultrasonography in rheumatoid arthritis management: the ECHO study. Lara D. Veeken. 59(10). 2746–2753. 7 indexed citations
4.
Pope, Janet, Emmanouil Rampakakis, Julie Vaillancourt, et al.. (2019). An open-label randomized controlled trial of DMARD withdrawal in RA patients achieving therapeutic response with certolizumab pegol combined with DMARDs. Lara D. Veeken. 59(7). 1522–1528. 10 indexed citations
5.
Rampakakis, Emmanouil, Julie Vaillancourt, Sara Mursleen, & John S. Sampalis. (2018). Healthcare Resource Utilization and Cost of Invasive Meningococcal Disease in Ontario, Canada. The Pediatric Infectious Disease Journal. 38(3). 253–257. 3 indexed citations
6.
Dang‐Tan, Tam, Shiyuan Zhang, Afisi Ismaila, et al.. (2017). The Burden of Illness Related to Chronic Obstructive Pulmonary Disease Exacerbations in Québec, Canada. Canadian Respiratory Journal. 2017. 1–10. 5 indexed citations
7.
Zhang, Shiyuan, Tam Dang‐Tan, Afisi Ismaila, et al.. (2016). The Impact of Adherence and Exacerbation Frequency on Health Care Utilization and Associated Direct Costs in Severe Asthma. CHEST Journal. 150(4). 827A–827A. 2 indexed citations
8.
Zhang, William, Tam Dang‐Tan, Afisi Ismaila, et al.. (2016). The healthcare burden of non-compliance to pharmacotherapeutic escalation recommendations for COPD. PA300–PA300. 1 indexed citations
9.
Ismaila, Afisi, et al.. (2014). Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients. Current Medical Research and Opinion. 30(7). 1427–1436. 42 indexed citations
10.
Ismaila, Afisi, Julie Vaillancourt, D. G. PARSONS, et al.. (2014). Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients. Current Medical Research and Opinion. 30(7). 1417–1425. 37 indexed citations
11.
Madan, Mina, Emmanouil Rampakakis, Anup Kumar Gupta, et al.. (2012). A Randomized Trial Assessing the Effectiveness of Ezetimibe in South Asian Canadians with Coronary Artery Disease or Diabetes: The INFINITY Study. SHILAP Revista de lepidopterología. 2012. 1–11. 8 indexed citations
12.
Khraishi, Majed, Don MacDonald, Emmanouil Rampakakis, Julie Vaillancourt, & John S. Sampalis. (2011). Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts. Clinical Rheumatology. 30(7). 877–885. 62 indexed citations
13.
Sampalis, John S., et al.. (2011). Long-term impact of adherence to oral bisphosphonates on osteoporotic fracture incidence. Journal of Bone and Mineral Research. 27(1). 202–210. 46 indexed citations
14.
15.
Dolovich, Lisa, et al.. (1998). Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ. 317(7162). 839–843. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francisco J. Schneuer Breakdown of academic impact, for papers by Mitsuyo Kinjo Breakdown of academic impact, for papers by Erik van Beek Breakdown of academic impact, for papers by Tuncay Küçüközkan Breakdown of academic impact, for papers by Arie Dekel Breakdown of academic impact, for papers by Joseph Onwude Breakdown of academic impact, for papers by Ümit Göktolga Breakdown of academic impact, for papers by Rivka Farkash Breakdown of academic impact, for papers by Howard T. Sharp Breakdown of academic impact, for papers by Chiann‐Yi Hsu
Rankless by CCL
2026